Kenyans living with HIV have received a major boost following Wednesday’s announcement that the government has committed to invest Sh7.5 billion annually on a local plant that will make anti-Aids drugs.
The partnership with the Global Fund, and the US President’s Emergency Plan for Aids Relief (PEPFAR) will produce Dolutegravir (DTG) – an anti-Aids drug with roots in India.
